10/08/2025
3:45 PM | Lite Strategy, Inc. (Filer)
Lite Strategy (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/06/2025
3:00 PM | Lee Charles Benjamin (Reporting)
Lite Strategy, Inc. (Issuer)
Lite Strategy (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2025
3:00 PM | Lite Strategy, Inc. (Filer)
Lite Strategy (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/15/2025
3:00 PM | Lite Strategy, Inc. (Filer)
Lite Strategy (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2025
3:38 PM | Lite Strategy, Inc. (Subject)
Lite Strategy (Subject)
Schornstein Alexander (Filed by)
| Form SCHEDULE 13G/A | |
09/10/2025
3:40 PM | Lite Strategy, Inc. (Issuer)
Lite Strategy (Issuer)
Schornstein Alexander (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/10/2025
8:00 AM | MEI Pharma, Inc. (Filer)
Lite Strategy (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2025
11:15 PM | MEI Pharma, Inc. (Filer)
Lite Strategy (Filer)
| Form EFFECT | |
09/05/2025
3:36 PM | MEI Pharma, Inc. (Filer)
Lite Strategy (Filer)
| Form 424B3 | |
08/26/2025
4:21 PM | MEI Pharma, Inc. (Filer)
Lite Strategy (Filer)
| Form S-3/A | |
08/20/2025
4:56 PM | MEI Pharma, Inc. (Issuer)
Lite Strategy (Issuer)
Riezman Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for LITS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lite Strategy and its competitors with MarketBeat's FREE daily newsletter. |
08/20/2025
4:54 PM | MEI Pharma, Inc. (Issuer)
Lite Strategy (Issuer)
Riezman Joshua (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2025
4:32 PM | MEI Pharma, Inc. (Subject)
Lite Strategy (Subject)
Schornstein Alexander (Filed by)
| Form SCHEDULE 13G | |
08/05/2025
7:05 AM | MEI Pharma, Inc. (Filer)
Lite Strategy (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2025
3:40 PM | MEI Pharma, Inc. (Filer)
Lite Strategy (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2025
4:23 PM | CITADEL ADVISORS LLC (Filed by)
MEI Pharma, Inc. (Subject)
Lite Strategy (Subject)
| Form SCHEDULE 13G | |
07/28/2025
6:20 PM | Anson Funds Management LP (Reporting)
MEI Pharma, Inc. (Subject)
Lite Strategy (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2025
6:18 PM | Funicular Funds, LP (Reporting)
MEI Pharma, Inc. (Subject)
Lite Strategy (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2025
4:22 PM | MEI Pharma, Inc. (Filer)
Lite Strategy (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2025
8:33 PM | DRISCOLL FREDERICK W (Reporting)
MEI Pharma, Inc. (Issuer)
Lite Strategy (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
8:36 PM | File Justin J. (Reporting)
MEI Pharma, Inc. (Issuer)
Lite Strategy (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
8:36 PM | Flynn James P (Reporting)
MEI Pharma, Inc. (Issuer)
Lite Strategy (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
8:38 PM | Glover Nicholas (Reporting)
MEI Pharma, Inc. (Issuer)
Lite Strategy (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
8:39 PM | MEI Pharma, Inc. (Issuer)
Lite Strategy (Issuer)
Reynolds Thomas C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
8:40 PM | MEI Pharma, Inc. (Issuer)
Lite Strategy (Issuer)
Wood Steven D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:30 PM | MEI Pharma, Inc. (Filer)
Lite Strategy (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
4:10 PM | MEI Pharma, Inc. (Filer)
Lite Strategy (Filer)
| Form DEF 14A | |
12/20/2024
4:15 PM | MEI Pharma, Inc. (Filer)
Lite Strategy (Filer)
| Form DEFA14A | |
12/20/2024
4:20 PM | MEI Pharma, Inc. (Filer)
Lite Strategy (Filer)
| Form ARS | |
